Imunon, Inc. Files 8-K: Other Events & Financials
Ticker: IMNN · Form: 8-K · Filed: Jul 22, 2025 · CIK: 749647
Sentiment: neutral
Topics: 8-K, financial-statements, other-events
TL;DR
IMUN filed an 8-K for other events and financials, no major news yet.
AI Summary
Imunon, Inc. filed an 8-K on July 22, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material changes, but rather serves as a notification of these categories being addressed.
Why It Matters
This 8-K filing indicates that Imunon, Inc. is providing updates on its financial statements and other events, which is a standard disclosure requirement for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific material disclosures, suggesting no immediate new risks.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- July 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-15911 (filing_id) — Commission File Number
- 52-1256615 (tax_id) — IRS Employer Identification No.
- 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Imunon, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item, but does not provide specific details about what those events are within the provided text.
What is the significance of Imunon, Inc. filing 'Financial Statements and Exhibits'?
This indicates that the company is providing or updating its financial information and related exhibits as required by regulatory filings.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 22, 2025.
What is Imunon, Inc.'s state of incorporation and commission file number?
Imunon, Inc. is incorporated in Delaware and its commission file number is 001-15911.
Where are Imunon, Inc.'s principal executive offices located?
Imunon, Inc.'s principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding Imunon, Inc. (IMNN).